Need professional-grade analysis? Visit stockanalysis.com
$23.28M
N/A
82
13.70%
CryoCell International Inc (CCEL) trades on United States in USD. The company is classified in the Healthcare sector under the Medical Care Facilities industry. The stock currently trades at $3.91, up 9.21% from the previous close.
Over the past year, CCEL has traded between a low of $2.92 and a high of $5.48. The stock has lost 27.1% over this period. It is currently 28.7% below its 52-week high.
CryoCell International Inc has a market capitalization of $23.28M and a dividend yield of 13.70%.
Cryo-Cell International, Inc. engages in cord blood and cord tissue cryopreservation services in the United States. The company offers cellular processing and cryogenic storage for family use, primarily for collection and preservation of umbilical cord blood, and tissue stem cells; and cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. It is also involved in the manufacturing of PrepaCyte CB processing system units for processing umbilical cord blood stem cells. In addition, the company provides cold storage services to third-party pharmaceutical companies and medical institutions. It markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. The company was incorporated in 1989 and is headquartered in Oldsmar, Florida.
Side-by-side comparison against top Healthcare peers.